Institution statistics

STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS - Netherlands 

Ranking results:

Past rankings:
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
2016
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Networking Rank (Reputation):900-1000
2015
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):800-900
Partner Constancy:100-200
Project Leadership Index:700-800
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 66
As coordinator: 4
As participant: 55
Sole participant: 7
Coordinator / Participant Ratio: 0.07*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 11.198.734 1.178.630 3
2018 4.477.125 5.156.199 4.906.450 2 1
2017 2.405.625 30.377.623 5.999.702 1 6
2016 0 37.644.786 2.481.225 6
2015 7.983.356 25.769.292 6.064.192 2 6
2014 0 1.999.360 1.999.360 1
2013 3.017.790 52.467.978 13.304.724 1 10
2012 0 28.746.190 4.016.436 5
2011 6.516.690 53.962.137 12.671.297 4 11
2010 161.249 23.777.929 7.295.569 1 6
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE12
EUROPEAN MOLECULAR BIOLOGY LABORATORY11
KAROLINSKA INSTITUTE11
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE10
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM10
ACADEMISCH ZIEKENHUIS LEIDEN9
KATHOLIEKE UNIVERSITEIT LEUVEN8
ACADEMISCH ZIEKENHUIS GRONINGEN6
INSTITUT CURIE6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE6
UNIVERSITY OF COPENHAGEN6
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON5
GENOME RESEARCH5
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
INSTITUT GUSTAVE ROUSSY4
INSTITUT PASTEUR4
MASARYKOVA UNIVERZITA4
MEDICAL RESEARCH COUNCIL4
OSLO UNIVERSITETSSYKEHUS HF4
STICHTING KATHOLIEKE UNIVERSITEIT4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
UNIVERSITEIT UTRECHT4
UNIVERSITY COLLEGE LONDON4
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE4
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
AGENDIA NV3
CANCER RESEARCH UK3
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE3
CONSIGLIO NAZIONALE DELLE RICERCHE3
DANMARKS TEKNISKE UNIVERSITET3
FORSCHUNGSVERBUND BERLIN EV3
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG3
INSTITUT CATALA D'ONCOLOGIA3
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL3
ISTITUTO EUROPEO DI ONCOLOGIA3
LUNDS UNIVERSITET3
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3
OULUN YLIOPISTO3
THE CHRISTIE NHS FOUNDATION TRUST3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAT AUTONOMA DE BARCELONA3
UNIVERSITE DE GENEVE3
UNIVERSITY OF HELSINKI3
AARHUS UNIVERSITETSHOSPITAL2
AMSTERDAM BIOTHERAPEUTICS UNIT2
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE2
DANISH CANCER SOCIETY2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FUNDACAO CALOUSTE GULBENKIAN2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA2
HORIZON DISCOVERY LIMITED2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
INFRAFRONTIER2
INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE2
INSTITUT JULES BORDET2
INSTRUCT ACADEMIC SERVICES LIMITED2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW2
KAROLINSKA INSTITUTET2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
KOBENHAVNS UNIVERSITET2
MILTENYI BIOTEC2
NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN2
OCELLO BV2
OTTOVONGUERICKEUNIVERSITAET MAGDEBURG2
PHILIPS ELECTRONICS NEDERLAND B V2
PHILIPS MEDICAL SYSTEMS NEDERLAND BV2
PHILOGEN2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
RHEINISCHE FRIEDRICHWILHELMSUNIVERSITAT BONN2
SCIENCE AND TECHNOLOGY FACILITIES COUNCIL2
STICHTING ANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STOCKHOLMS LAENS LANDSTING2
TECHNISCHE UNIVERSITAET DRESDEN2
TECHNISCHE UNIVERSITEIT EINDHOVEN2
TEL AVIV UNIVERSITY2
THE ROYAL MARSDEN NATIONAL HEALTH SERVICE TRUST2
THE UNIVERSITY OF SHEFFIELD2
TORONTO CENTRE FOR PHENOGENOMICS INC2
TSE SYSTEMS2
UNIVERSIDADE NOVA DE LISBOA2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITAET BASEL2
UNIVERSITAET DES SAARLANDES2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITAIR ZIEKENHUIS ANTWERPEN2
UNIVERSITEIT GENT2
UNIVERSITEIT LEIDEN2
Constancy:

Total number of partners:644

Partner loyalty:
Frequent Partner: (> 2 projects): 224
Rare Partner: 420

Frequent / Rare Partner Ratio: 0.53

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES28
RTD HORIZONTAL TOPICS9
SOCIAL AND ECONOMIC CONCERNS6
INDUSTRY AND TECHNOLOGY2
ENERGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response aDDRessparticipant4.011.93919
2019-01-01Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life PREFERABLEparticipant3.983.34712
2019-01-01Training network in drug discovery targeting TRIM Ubiquitin ligases in disease TRIM-NETparticipant3.203.44814
2018-10-01Senescence therapy for cancer SENCANcoordinator2.478.7501
2018-04-01Cohesin-mediated chromosomal looping: From linear paths to 3D effects CohesinLoopingcoordinator1.998.3751
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2017-12-01Sensitivity of human tumors to T cell attack SENSITcoordinator2.405.6251
2017-11-01Training Network on Automatic Processing of PAthological Speech TAPASparticipant3.856.02912
2017-06-01Implications of Medical Low Dose Radiation Exposure MEDIRADparticipant9.995.14633
2017-03-01Genomics of Chromosome Architecture and Dynamics in Single Cells GoCADiSCparticipant2.497.1251
2017-01-01Regulated Assembly of Molecular Machines for DNA REPAIR: a Molecular Analysis training Network DNAREPAIRMANparticipant3.079.27014
2017-01-01Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABRparticipant5.994.17617
2017-01-01Towards enduring mouse resources and services advancing research into human health and disease INFRAFRONTIER2020participant4.955.87729
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20956
2016-09-01Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network SYNTRAINparticipant3.990.26913
2016-06-01Advancing Smart Optical Imaging and Sensing for Health ASTONISHparticipant5.895.04624
2016-05-01A treatment for BRAF inhibitor resistant melanoma 2MoveMate4Melanomaparticipant149.7501
2016-03-01Generation of the CanPath prototype - a platform for predictive cancer pathway modeling CanPathProparticipant9.862.5469
2016-01-01DC-based immunotherapy to treat Malignant Mesothelioma H2020MM04participant5.782.9658
2015-11-01World-wide E-infrastructure for structural biology West-Lifeparticipant3.981.12510
2015-10-01Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) MoTriColorparticipant5.996.99211
2015-10-01Cancer treatment during pregnancy: from fetal safety to maternal efficacy CRADLEparticipant2.000.0002
2015-10-01Leading Innovative measures to reach gender Balance in Research Activities LIBRAparticipant2.291.64111
2015-09-01From haplotype to phenotype: a systems integration of allelic variation, chromatin state and 3D genome data HAP-PHENparticipant1.500.0001
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTcoordinator5.983.35613
2015-09-01Tumor cell death supports recurrence of cancer Cancer-Recurrencecoordinator2.000.0002
2015-09-01Infrastructure for NMR, EM and X-rays for translational research iNEXTparticipant9.999.53425
2014-03-01Mechanistic insights into the impact of tumor-associated neutrophils on metastatic breast cancer INFLAMETparticipant1.999.3601
2013-12-01Advanced T-cell Engineered for Cancer Therapy ATECTparticipant5.931.1515
2013-10-01The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy PLOIDYNETcoordinator3.017.79011
2013-10-01The European non-coding RNA network RNATRAINparticipant3.474.40011
2013-09-01Breast biopsy system guided by Positron Emission Mammography allowing real-time 3D visualization of tumour lesion and needle insertion guidance for higher sampling accuracy and efficiency MAMMOCAREparticipant1.077.0007
2013-05-01Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer SUPERSISTparticipant5.999.9975
2013-05-01Combination therapies for personalized cancer medicine COMBATCANCERparticipant14.580.5582
2013-05-01Quantitative T cell Immunology QUANTIparticipant4.012.57012
2013-04-01Identification and functional validation of drugable targets/pathways for triple negative breast cancer TRIPLE-BCparticipant2.495.1023
2013-02-01Digital radiation therapy patient DR THERAPATparticipant3.502.0008
2013-01-01Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation INFRAFRONTIER-I3participant9.900.00023
2013-01-01Identification of Host Determinants for Virus Entry using a Haploid Genetic Approach VIRAL HOST FACTORSparticipant1.495.2001
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00016
2012-11-01Tumor Infiltrating Myeloid Cell Compartment TIMCCparticipant3.756.4698
2012-10-01Rational molecular Assessments and Innovative Drug Selection RAIDSparticipant5.999.64216
2012-03-01Principles of Chromatin Organization CHROMATINPRINCIPLESparticipant2.495.0801
2012-01-01Building data bridges between biological and medical infrastructures in Europe BIOMEDBRIDGESparticipant10.494.99925
2011-11-01European Research Training in the Ubiquitin Proteasome System UPStreamparticipant3.307.40910
2011-11-01CAncer Risk and INsulin analoGues CARINGparticipant2.974.1747
2011-11-01Decoding the ubiquitin code UBICODEparticipant1.498.2401
2011-06-01Innate and adaptive immune cell contribution to the pre-metastatic niche BMDCMETcoordinator184.0411
2011-05-01Mapping the life histories of T cells Life-his-Tparticipant2.499.6401
2011-04-01barcoding approach for dendritic cells differentiation BARDIFcoordinator176.1861

overview shows latest 50 from 66 projects (2000-01-01 - 2019-12-31)
A full list of projects can be found here:
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum